| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $45.18B | +15.9% |
| Cost of Revenue | $23.28B | +10.6% |
| R&D Expense | $3.39B | +15.9% |
| SG&A Expense | $1.89B | +10.9% |
| Operating Income | $13.33B | +27.9% |
| Pre-tax Income | $12.72B | +27.7% |
| Income Tax | $1.74B | +38.9% |
| Net Income | $10.98B | +26.1% |
| EPS (Basic) | $2.58 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.03B | +15.7% |
| Short-term Investments | $28.7M | -98.4% |
| Current Assets | $13.02B | -0.6% |
| Total Assets | $55.60B | +3.7% |
| Current Liabilities | $10.98B | +2.1% |
| Long-term Debt | $13.46B | -2.4% |
| Total Liabilities | $28.98B | +0.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.15B | +37.9% |
| Capital Expenditures | $688.2M | +56.6% |
| Investing Cash Flow | $1.04B | +147.7% |
| Financing Cash Flow | -$10.35B | -153.9% |
| Free Cash Flow | $9.46B | +36.7% |
| -87.3% |
| EPS (Diluted) | $2.53 | -87.2% |
| Stockholders' Equity |
| $26.62B |
| +7.6% |